Log in or Sign up for Free to view tailored content for your specialty!
Lupus News
Hydroxychloroquine no longer best treatment for systemic dermatomyositis
DESTIN, Fla. — Hydroxychloroquine may no longer be the optimal treatment option for systemic dermatomyositis, according to data presented at the Congress of Clinical Rheumatology East.
Future of lupus management may require further disease subdivision
DESTIN, Fla. — Systemic lupus erythematosus may benefit from being redefined and further subdivided, depending on the autoantibody profile of the patient, according to a speaker at the Congress of Clinical Rheumatology East 2022.
Log in or Sign up for Free to view tailored content for your specialty!
Nephritis, phospholipid antibodies contribute to cardiovascular risk in lupus
DESTIN, Fla. — Nephritis and phospholipid antibodies should be considered as contributors to cardiovascular disease risk in patients with systemic lupus erythematosus, according to a speaker at the Congress of Clinical Rheumatology East.
‘Get rid of maintenance prednisone’: Steroid-sparing critical for non-renal lupus
Although patients with lupus nephritis may require prednisone maintenance, attempts should be made to reduce their steroid doses, said a speaker at The Future of Systemic Lupus Erythematosus Diagnosis and Treatment meeting.
‘The effects of racism’: Patients of color with lupus experience diagnostic delays
People of color with lupus are more likely to experience delayed diagnosis along with greater rates of morbidity and mortality, compared with white patients, according to data.
Children with lupus at higher COVID-19 hospitalization risk vs. those with JIA
Children and adolescents with rheumatic and musculoskeletal diseases who contract COVID-19 are not likely to require hospitalization, according to data published in the Annals of the Rheumatic Diseases.
New drugs, new guidelines: ACR/AAHKS update treatment recommendations in joint replacement
Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.
Long-term remission rare outcome in cutaneous lupus erythematosus
Researchers found that long-term remission of cutaneous lupus erythematosus occurred in nearly 20% of patients, according to a study published in the Journal of American Academy of Dermatology.
Racial inequities remain in pediatric lupus care despite overall outcome improvements
Children with lupus of all racial and ethnic groups have experienced reduced of end-stage renal disease and dialysis, but the overall improvement has failed to close the outcome gap between Black and white patients, researchers noted.
EULAR: ‘Never too late’ for patients with rheumatic disease to start exercising
Patients with rheumatic and musculoskeletal diseases should engage in both aerobic and strengthening exercises, aiming for at least moderate intensity, according to new EULAR recommendations.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read